Literature DB >> 19592674

Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice.

Jurjen S Lagas1, Maria L H Vlaming, Alfred H Schinkel.   

Abstract

A TP-binding cassette (ABC) multidrug transporters are cellular efflux pumps with broad and often widely overlapping substrate specificities. They can have a major impact on the pharmacokinetics and hence overall pharmacological behavior of many drugs. To study their separate roles and functional overlap, or complementarity, a collection of mice deficient in two or more ABC transporters has been generated. This review discusses recent findings obtained with these models, focusing on pharmacokinetic studies with a number of clinically relevant drugs. In addition, the characterization of these mice and some physiological aspects of ABC multidrug transporters are addressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592674     DOI: 10.1124/mi.9.3.7

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  21 in total

1.  Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.

Authors:  Sagar Agarwal; Yasuo Uchida; Rajendar K Mittapalli; Ramola Sane; Tetsuya Terasaki; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2012-03-08       Impact factor: 3.922

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  Vectorial ligand transport through mammalian choroid plexus.

Authors:  Reynold Spector; Conrad E Johanson
Journal:  Pharm Res       Date:  2010-05-15       Impact factor: 4.200

Review 4.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

5.  Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1.

Authors:  Qing Li; Hyekyung Yang; Xiujuan Peng; Dong Guo; Zhongqi Dong; James E Polli; Yan Shu
Journal:  Mol Pharm       Date:  2013-06-03       Impact factor: 4.939

6.  Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate.

Authors:  Severin Mairinger; Oliver Langer; Claudia Kuntner; Thomas Wanek; Jens P Bankstahl; Marion Bankstahl; Johann Stanek; Bernd Dörner; Florian Bauer; Christoph Baumgartner; Wolfgang Löscher; Thomas Erker; Markus Müller
Journal:  Nucl Med Biol       Date:  2010-04-08       Impact factor: 2.408

7.  Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

Authors:  Louise Karlsson; Christoph Hiemke; Björn Carlsson; Martin Josefsson; Johan Ahlner; Finn Bengtsson; Ulrich Schmitt; Fredrik C Kugelberg
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

Review 8.  Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.

Authors:  Mitchell P McInerney; Jennifer L Short; Joseph A Nicolazzo
Journal:  AAPS J       Date:  2017-05-01       Impact factor: 4.009

Review 9.  Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Authors:  Xi-Ling Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Rev       Date:  2010-09-21       Impact factor: 4.518

10.  Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Authors:  Robert L Myette; Gwenaëlle Conseil; Sean P Ebert; Bryan Wetzel; Michael R Detty; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2013-03-25       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.